Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

Article  PubMed  Google Scholar 

Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245–55.

Article  PubMed  Google Scholar 

Tangkijvanich P, Mahachai V, Suwangool P, Poovorawan Y. Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma. World J Gastroenterol. 2004;10:1547–50.

Article  PubMed  PubMed Central  Google Scholar 

Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer. 2004;101:796–802.

Article  PubMed  Google Scholar 

Farinati F, Sergio A, Giacomin A, Di Nolfo MA, Del Poggio P, Benvegnù L, et al. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? Eur J Gastroenterol Hepatol. 2009;21:1212–8.

Article  CAS  PubMed  Google Scholar 

Kang SH, Kim DY, Jeon SM, Ahn SH, Park JY, Kim SU, et al. Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels. Eur J Gastroenterol Hepatol. 2012;24:849–56.

Article  CAS  PubMed  Google Scholar 

Hiraoka A, Michitaka K, Kumada T, Izumi N, Kadoya M, Kokudo N, et al. Validation and potential of albumin-bilirubin grade and prognostication in a nationwide survey of 46,681 hepatocellular carcinoma patients in Japan: the need for a more detailed evaluation of hepatic function. Liver Cancer. 2017;6:325–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng A-L, Qin S, Ikeda M, Galle PR, Ducreux M, Kim T-Y, et al. Updated efficacy and safety data from IMbrave150: Atezolizumab plus Bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. J Hepatol. 2022;76:862–73.

Article  CAS  PubMed  Google Scholar 

Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M, et al. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. J Hepatol. 2016;65:938–43.

Article  PubMed  Google Scholar 

Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M, et al. Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: a Japanese nationwide survey. Hepatology. 2017;66:510–7.

Article  CAS  PubMed  Google Scholar 

Huang Y-J, Hsu H-C, Wang C-Y, Wang C-J, Chen H-C, Huang E-Y, et al. The treatment responses in cases of radiation therapy to portal vein thrombosis in advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2009;73:1155–63.

Article  PubMed  Google Scholar 

Yoon SM, Lim Y-S, Won HJ, Kim JH, Kim KM, Lee HC, et al. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. Int J Radiat Oncol Biol Phys. 2012;82:2004–11.

Article  PubMed  Google Scholar 

Tanaka Y, Nakazawa T, Komori S, Hidaka H, Okuwaki Y, Takada J, et al. Radiotherapy for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels: efficacy and outcomes. J Gastroenterol Hepatol. 2014;29:352–7.

Article  PubMed  Google Scholar 

Nakazawa T, Hidaka H, Shibuya A, Okuwaki Y, Tanaka Y, Takada J, et al. Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis. BMC Gastroenterol. 2014;14:84.

Article  PubMed  PubMed Central  Google Scholar 

Kanai T, Endo M, Minohara S, Miyahara N, Koyama-ito H, Tomura H, et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys. 1999;44:201–10.

Article  CAS  PubMed  Google Scholar 

Abe T, Saitoh J-I, Kobayashi D, Shibuya K, Koyama Y, Shimada H, et al. Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma. Radiat Oncol. 2015;10:187.

Article  PubMed  PubMed Central  Google Scholar 

Shiba S, Shibuya K, Kawashima M, Okano N, Kaminuma T, Okamoto M, et al. Comparison of dose distributions when using carbon ion radiotherapy versus intensity-modulated radiotherapy for hepatocellular carcinoma with macroscopic vascular invasion: a retrospective analysis. Anticancer Res. 2020;40:459–64.

Article  CAS  PubMed  Google Scholar 

Kato H, Tsujii H, Miyamoto T, Mizoe J-E, Kamada T, Tsuji H, et al. Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys. 2004;59:1468–76.

Article  PubMed  Google Scholar 

Kasuya G, Kato H, Yasuda S, Tsuji H, Yamada S, Haruyama Y, et al. Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: combined analyses of 2 prospective trials. Cancer. 2017;123:3955–65.

Article  CAS  PubMed  Google Scholar 

Yasuda S, Kato H, Imada H, Isozaki Y, Kasuya G, Makishima H, et al. Long-term results of high-dose 2-Fraction Carbon Ion Radiation Therapy for Hepatocellular Carcinoma. Adv Radiat Oncol. 2020;5:196–203.

Article  PubMed  Google Scholar 

Shibuya K, Katoh H, Koyama Y, Shiba S, Okamoto M, Okazaki S, et al. Efficacy and safety of 4 fractions of Carbon-Ion Radiation Therapy for Hepatocellular Carcinoma: a prospective study. Liver Cancer. 2022;11:61–74.

Article  CAS  PubMed  Google Scholar 

Suzuki M, Kase Y, Yamaguchi H, Kanai T, Ando K. Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in Chiba (HIMAC) carbon-ion beams. Int J Radiat Oncol Biol Phys. 2000;48:241–50.

Article  CAS  PubMed  Google Scholar 

Furukawa T, Inaniwa T, Sato S, Shirai T, Takei Y, Takeshita E, et al. Performance of the NIRS fast scanning system for heavy-ion radiotherapy. Med Phys. 2010;37:5672–82.

Article  PubMed  Google Scholar 

Iwata Y, Fujimoto T, Matsuba S, Fujita T, Sato S, Furukawa T, et al. Recent progress of a superconducting rotating-gantry for carbon-ion radiotherapy. Nucl Instrum Methods Phys Res B. 2017;406:338–42.

Article  CAS  Google Scholar 

Endo M, Koyama-Ito H, Minohara S, Miyahara N, Tamura H, Kanai T, et al. HIPLAN-a heavy ion treatment planning system at HIMAC. J Jpn Soc Ther Radiol Oncol. 1996;8:231–8.

Google Scholar 

Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002;53:810–21.

Article  PubMed  Google Scholar 

Guglielmi A, Ruzzenente A, Conci S, Valdegamberi A, Iacono C. How much remnant is enough in liver resection? Dig Surg. 2012;29:6–17.

Article  PubMed  Google Scholar 

Minohara S, Kanai T, Endo M, Noda K, Kanazawa M. Respiratory gated irradiation system for heavy-ion radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47:1097–103.

Article  CAS  PubMed  Google Scholar 

Kato H, Yamada S, Yasuda S, Yamaguchi K, Kitabayashi H, Kamada T, et al. Two-fraction carbon ion radiotherapy for hepatocellular carcinoma: preliminary results of a phase I/II clinical trial. J Clin Oncol. 2005;23:4124.

Article  Google Scholar 

Shibuya K, Ohno T, Terashima K, Toyama S, Yasuda S, Tsuji H, et al. Short-course carbon-ion radiotherapy for hepatocellular carcinoma: a multi-institutional retrospective study. Liver Int. 2018;38:2239–47.

Article  CAS  PubMed  Google Scholar 

Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc J-F, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378–90.

Article  CAS  PubMed  Google Scholar 

Shiba S, Shibuya K, Okamoto M, Okazaki S, Komatsu S, Kubota Y, et al. Clinical impact of hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma. Radiat Oncol. 2020;15:195.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mizumoto M, Ogino H, Okumura T, Terashima K, Murakami M, Ogino T, et al. Proton Beam Therapy for Hepatocellular Carcinoma: Multicenter prospective Registry Study in Japan. Int J Radiat Oncol Biol Phys. 2023. https://doi.org/10.1016/j.ijrobp.2023.09.047.

Article  PubMed  Google Scholar 

Matsuo Y, Yoshida K, Nishimura H, Ejima Y, Miyawaki D, Uezono H, et al. Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy. J Radiat Res. 2016;57:512–23.

Article  PubMed  PubMed Central  Google Scholar 

Rim CH, Kim CY, Yang DS, Yoon WS. Comparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis and systematic review. Radiother Oncol. 2018;129:112–22.

Article  PubMed  Google Scholar 

Wu G, Huang G, Huang J, Lu L, Peng S, Li Y, et al. Comparison of External Beam Radiation Therapy modalities for Hepatocellular Carcinoma with Macrovascular Invasion: a Meta-analysis and systematic review. Front Oncol. 2022;12:829708.

Article  PubMed  PubMed Central  Google Scholar 

Hata M, Tokuuye K, Sugahara S, Kagei K, Igaki H, Hashimoto T, et al. Proton Beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer. 2005;104:794–801.

Article